• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?

作者信息

Vuorio Alpo, Raal Frederick J, Kovanen Petri T

机构信息

Mehiläinen Airport Health Centre, Vantaa, Finland.

Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Front Cardiovasc Med. 2025 Jul 1;12:1624049. doi: 10.3389/fcvm.2025.1624049. eCollection 2025.

DOI:10.3389/fcvm.2025.1624049
PMID:40666429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12261449/
Abstract
摘要

相似文献

1
Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?家族性高胆固醇血症患者中脂蛋白(a)和低密度脂蛋白胆固醇水平升高：双重一级预防是否已近在眼前？
Front Cardiovasc Med. 2025 Jul 1;12:1624049. doi: 10.3389/fcvm.2025.1624049. eCollection 2025.
2
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?家族性高胆固醇血症与脂蛋白(a)：一对犯罪同伙？
Curr Atheroscler Rep. 2022 Jun;24(6):427-434. doi: 10.1007/s11883-022-01019-5. Epub 2022 Apr 7.
3
Familial Hypercholesterolemia家族性高胆固醇血症
4
Statins for children with familial hypercholesterolemia.用于患有家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD006401. doi: 10.1002/14651858.CD006401.pub4.
5
Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis.非他汀类降脂疗法对心血管风险增加的高胆固醇血症患者的疗效比较：一项网状Meta分析
Curr Med Res Opin. 2022 May;38(5):777-784. doi: 10.1080/03007995.2022.2049164. Epub 2022 Mar 20.
6
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.脂蛋白吸附治疗起始于儿童期的纯合子家族性高胆固醇血症患者的心血管结局：来自两个登记处的国际队列的长期随访。
Lancet Child Adolesc Health. 2024 Jul;8(7):491-499. doi: 10.1016/S2352-4642(24)00073-7. Epub 2024 May 14.
7
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial.inclisiran治疗基因确诊的纯合子家族性高胆固醇血症青少年的疗效和安全性：ORION-13随机试验双盲、安慰剂对照部分的结果
Circulation. 2025 Jun 24;151(25):1758-1766. doi: 10.1161/CIRCULATIONAHA.124.073233. Epub 2025 May 20.
8
Evinacumab-dgnb (Evkeeza-REGN1500), A Novel Lipid-Lowering Therapy for Homozygous Familial Hypercholesterolemia.依洛尤单抗（瑞百安），一种用于治疗纯合子家族性高胆固醇血症的新型降脂疗法。
Cardiol Rev. 2024;32(2):180-185. doi: 10.1097/CRD.0000000000000522. Epub 2023 Apr 18.
9
Statins for children with familial hypercholesterolemia.用于家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2010 Jul 7(7):CD006401. doi: 10.1002/14651858.CD006401.pub2.
10
Lipoprotein X - Pathophysiology, diagnosis, and management.脂蛋白X——病理生理学、诊断与管理
J Clin Lipidol. 2025 Jun 2. doi: 10.1016/j.jacl.2025.05.015.

本文引用的文献

1
Association Between Lipoprotein(a) and Arterial Stiffness in Young Adults with Familial Hypercholesterolemia.家族性高胆固醇血症青年成人中脂蛋白(a)与动脉僵硬度之间的关联
J Clin Med. 2025 Feb 27;14(5):1611. doi: 10.3390/jcm14051611.
2
Lipoprotein(a) - From Biomarker to Therapy: A Review for the Clinician.脂蛋白(a)——从生物标志物到治疗：临床医生综述
Am J Cardiol. 2025 Jun 15;245:42-53. doi: 10.1016/j.amjcard.2025.02.034. Epub 2025 Mar 6.
3
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease.脂蛋白(a)作为心血管疾病的一个因果风险因素。
Curr Cardiovasc Risk Rep. 2025;19(1):8. doi: 10.1007/s12170-025-00760-1. Epub 2025 Feb 18.
4
Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL.与低密度脂蛋白胆固醇（LDL-C）<70mg/dL和脂蛋白（a）<50mg/dL相关的脂质斑块特征的表征
J Clin Lipidol. 2025 May-Jun;19(3):509-520. doi: 10.1016/j.jacl.2024.12.019. Epub 2025 Jan 3.
5
Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.口服穆瓦拉普林降低脂蛋白(a)：一项随机临床试验。
JAMA. 2025 Jan 21;333(3):222-231. doi: 10.1001/jama.2024.24017.
6
The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report.德国脂蛋白吸附治疗登记处-第十一次年度报告摘要。
Atherosclerosis. 2024 Nov;398:118601. doi: 10.1016/j.atherosclerosis.2024.118601. Epub 2024 Sep 19.
7
Extension of Heterozygous Familial Hypercholesterolemia Treatment Recommendations by Including Both Low-density Lipoprotein and Lipoprotein(a) Burden - a Unique Opportunity to Improve Patient Prognosis.通过纳入低密度脂蛋白和脂蛋白(a)负担来扩展杂合子家族性高胆固醇血症的治疗建议——改善患者预后的独特机会。
Eur J Prev Cardiol. 2024 Sep 20. doi: 10.1093/eurjpc/zwae304.
8
Lipoprotein(a) in children and adolescents with genetically confirmed familial hypercholesterolemia followed up at a specialized lipid clinic.在一家专业脂质诊所随访的经基因确诊的家族性高胆固醇血症儿童和青少年中的脂蛋白(a) 。
Atheroscler Plus. 2024 Jun 20;57:13-18. doi: 10.1016/j.athplu.2024.06.002. eCollection 2024 Sep.
9
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study.依洛尤单抗与急性冠脉综合征后性别及脂蛋白（a）对心血管结局的影响：来自 ODYSSEY OUTCOMES 研究的报告。
J Clin Lipidol. 2024 Jul-Aug;18(4):e548-e561. doi: 10.1016/j.jacl.2024.04.122. Epub 2024 Apr 10.
10
Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options.治疗脂蛋白(a)升高的新型疗法：从传统药物到未来治疗选择
Life (Basel). 2024 Mar 12;14(3):374. doi: 10.3390/life14030374.